BR0210631A - Composição farmacêutica de liberação prolongada - Google Patents
Composição farmacêutica de liberação prolongadaInfo
- Publication number
- BR0210631A BR0210631A BR0210631-0A BR0210631A BR0210631A BR 0210631 A BR0210631 A BR 0210631A BR 0210631 A BR0210631 A BR 0210631A BR 0210631 A BR0210631 A BR 0210631A
- Authority
- BR
- Brazil
- Prior art keywords
- extended release
- pharmaceutical composition
- composition
- release pharmaceutical
- mini
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nanotechnology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPR6025A AUPR602501A0 (en) | 2001-06-29 | 2001-06-29 | Sustained release pharmaceutical composition |
| PCT/AU2002/000865 WO2003002102A1 (en) | 2001-06-29 | 2002-07-01 | Sustained release pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0210631A true BR0210631A (pt) | 2004-07-27 |
Family
ID=3829991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0210631-0A BR0210631A (pt) | 2001-06-29 | 2002-07-01 | Composição farmacêutica de liberação prolongada |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20040241204A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1411904A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4800570B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1731988A (cg-RX-API-DMAC7.html) |
| AU (2) | AUPR602501A0 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0210631A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2452030A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO5540373A2 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ529859A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003002102A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050129728A1 (en) * | 2001-09-11 | 2005-06-16 | Martinod Serge R. | Sustained release pharmaceutical composition |
| CN1638747A (zh) * | 2002-01-24 | 2005-07-13 | 斯玛特药物系统公司 | 持续释放药物组合物 |
| BRPI0511694A (pt) * | 2004-05-31 | 2008-01-08 | Smart Drug Systems Inc | composições de liberação controlada |
| JP2008502605A (ja) * | 2004-06-16 | 2008-01-31 | スマート ドラッグ システムズ インコーポレイティド | 徐放性ワクチン組成物 |
| AU2005253646B2 (en) * | 2004-06-16 | 2011-09-15 | Virbac Corporation | Sustained release vaccine composition |
| ES2432556T3 (es) | 2004-08-04 | 2013-12-04 | Evonik Corporation | Métodos para fabricar dispositivos de suministro y sus dispositivos |
| EP1859788A1 (en) * | 2006-05-24 | 2007-11-28 | Abbott GmbH & Co. KG | Production of enveloped pharmaceutical dosage forms |
| NZ552290A (en) * | 2006-12-21 | 2009-05-31 | Bomac Research Ltd | Tablet fomulation |
| BRPI0705822A2 (pt) * | 2007-10-25 | 2009-06-23 | Schering Plough Saude Animal Ltda | formulação injetável com ação prolongada e uso de um agente semi-sintético derivado do grupo das avermectinas, em combinação com um polìmero biodegradável |
| EP2222281B1 (en) | 2007-12-20 | 2018-12-05 | Evonik Corporation | Process for preparing microparticles having a low residual solvent volume |
| JP5632851B2 (ja) * | 2008-11-07 | 2014-11-26 | コンビネント・バイオメデイカル・システムズ・インコーポレーテツド | 疾患を処置および/若しくは予防するための装置および方法 |
| CN102355891A (zh) | 2009-03-17 | 2012-02-15 | 英特威国际有限公司 | 大环内酯药物递送系统 |
| AU2011260260B2 (en) * | 2010-06-01 | 2015-09-03 | Baxter Healthcare S.A. | Process for making dry and stable hemostatic compositions |
| PT2598151T (pt) * | 2010-07-30 | 2019-04-15 | Ceva Sante Animale Sa | Composições para o tratamento da infestação por vermes do coração |
| JP5696279B2 (ja) * | 2010-12-01 | 2015-04-08 | 学校法人自治医科大学 | 長期徐放型薬剤硬膜外腔留置システム |
| MX379693B (es) | 2011-12-02 | 2025-03-11 | Merial Ltd | Formulaciones de moxidectina inyectables de larga acción y formas de cristal de moxidectina novedosas. |
| US20130190839A1 (en) * | 2012-01-20 | 2013-07-25 | Jane Rapsey | Drug delivery using a sacrificial host |
| WO2014160026A2 (en) * | 2013-03-14 | 2014-10-02 | Endo Pharmaceuticals Solutions Inc. | Implantable drug delivery compositions comprising sugar-based sorption enhancers and methods of treatment thereof |
| AU2013209343B1 (en) * | 2013-05-14 | 2014-04-24 | Activesignal Holding Limited | Device for the Treatment of Bone Conditions |
| WO2016020901A1 (en) | 2014-08-07 | 2016-02-11 | Acerta Pharma B.V. | Methods of treating cancers, immune and autoimmune diseases, and inflammatory diseases based on btk occupancy and btk resynthesis rate |
| ITUB20153652A1 (it) | 2015-09-16 | 2017-03-16 | Fatro Spa | Microsfere contenenti lattoni macrociclici antielminitici |
| JP2021528452A (ja) * | 2018-06-25 | 2021-10-21 | タイタン ファーマシューティカルズ インコーポレイテッド | インプラントとして使用するための装填可能な多孔質構造 |
| US20220152044A1 (en) * | 2019-03-14 | 2022-05-19 | Palmaya Pty Ltd | Treatment of inflammatory diseases of the central nervous system |
| CN110559431B (zh) * | 2019-10-11 | 2023-02-28 | 南京农业大学 | 一种巨型艾美耳球虫纳米亚单位疫苗及其制备方法和应用 |
| US11529310B2 (en) | 2020-12-08 | 2022-12-20 | Ruminant Biotech Corp Limited | Devices and methods for delivery of substances to animals |
| US20240238226A1 (en) * | 2021-03-09 | 2024-07-18 | Adnan I. Qureshi | Implantable sustained release device and a method of use thereof |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3279996A (en) * | 1962-08-28 | 1966-10-18 | Jr David M Long | Polysiloxane carrier for controlled release of drugs and other agents |
| US4053580A (en) * | 1975-01-01 | 1977-10-11 | G. D. Searle & Co. | Microsealed pharmaceutical delivery device |
| US4331652A (en) * | 1979-09-12 | 1982-05-25 | Eli Lilly And Company | Controlled release parasitic formulations and method |
| US4723958A (en) * | 1986-05-23 | 1988-02-09 | Merck & Co., Inc. | Pulsatile drug delivery system |
| US5028430A (en) * | 1987-05-08 | 1991-07-02 | Syntex (U.S.A.) Inc. | Delivery systems for the controlled administration of LHRH analogs |
| ATE90203T1 (de) * | 1989-03-17 | 1993-06-15 | Pitman Moore Inc | Kontrollierte, verzoegerte wirkstofffreisetzung von makromolekularen proteinen. |
| ES2058923T3 (es) * | 1989-06-21 | 1994-11-01 | Univ Brown Res Found | Sistema para terapia neurologica. |
| FR2653338B1 (fr) * | 1989-10-23 | 1994-06-10 | Dow Corning Sa | Formulation pour des pansements a liberation prolongee de medicament et son utilisation. |
| JPH11508224A (ja) * | 1990-08-09 | 1999-07-21 | エンドコン・インコーポレーテッド | 多重ドラッグデリバリーシステム |
| NZ239370A (en) * | 1990-08-22 | 1994-04-27 | Merck & Co Inc | Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone |
| US5211951A (en) * | 1991-07-24 | 1993-05-18 | Merck & Co., Inc. | Process for the manufacture of bioerodible poly (orthoester)s and polyacetals |
| JPH06321803A (ja) * | 1993-05-17 | 1994-11-22 | Kirin Brewery Co Ltd | 水溶性ペプチドホルモンの徐放性製剤 |
| JP3720386B2 (ja) * | 1993-12-27 | 2005-11-24 | 住友製薬株式会社 | 薬物放出制御製剤 |
| FR2745180B1 (fr) * | 1996-02-23 | 1998-05-07 | Dow Corning Sa | Procede de fabrication de dispositifs a liberation controlee |
| EP1014970A1 (en) * | 1997-09-23 | 2000-07-05 | Pfizer Limited | Parasiticidal formulations |
| AUPP279698A0 (en) * | 1998-04-03 | 1998-04-30 | Sunscape Developments Limited | Sustained release formulation |
| WO2000003660A1 (en) * | 1998-07-17 | 2000-01-27 | Skyepharma, Inc. | Biodegradable compositions for the controlled release of encapsulated substances |
| GB9816132D0 (en) * | 1998-07-24 | 1998-09-23 | Norbrook Lab Ltd | Non-aqueous anthelmintic composition |
| WO2000013666A1 (en) * | 1998-09-05 | 2000-03-16 | Seung Jin Lee | Biodegradable particulate polymeric preparation and process for producing thereof |
| US6645192B2 (en) * | 1998-09-30 | 2003-11-11 | Ivy Animal Health, Inc. | Pellet implant system for immediate and delayed release of antiparasitic drug |
| AU6283299A (en) * | 1998-10-01 | 2000-04-17 | Elan Pharma International Limited | Controlled release nanoparticulate compositions |
| CA2379909C (en) * | 1999-08-06 | 2011-01-04 | Board Of Regents, The University Of Texas System | Drug releasing biodegradable fiber implant |
| TW524696B (en) * | 1999-11-10 | 2003-03-21 | Sumitomo Pharma | Sustained-release drug formulations |
| WO2001037811A1 (en) * | 1999-11-22 | 2001-05-31 | Akzo Nobel N.V. | Composition allowing predefined and controlled release of active ingredient, preparation thereof and use |
| US20020131988A1 (en) * | 1999-12-16 | 2002-09-19 | Foster Todd P. | Pharmaceutical implant containing immediate-release and sustained-release components and method of administration |
| US6998137B2 (en) * | 2000-04-07 | 2006-02-14 | Macromed, Inc. | Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
-
2001
- 2001-06-29 AU AUPR6025A patent/AUPR602501A0/en not_active Abandoned
-
2002
- 2002-07-01 CN CNA028131525A patent/CN1731988A/zh active Pending
- 2002-07-01 US US10/482,336 patent/US20040241204A1/en not_active Abandoned
- 2002-07-01 CA CA002452030A patent/CA2452030A1/en not_active Abandoned
- 2002-07-01 AU AU2002344685A patent/AU2002344685B2/en not_active Ceased
- 2002-07-01 NZ NZ529859A patent/NZ529859A/en not_active IP Right Cessation
- 2002-07-01 JP JP2003508341A patent/JP4800570B2/ja not_active Expired - Fee Related
- 2002-07-01 BR BR0210631-0A patent/BR0210631A/pt not_active IP Right Cessation
- 2002-07-01 WO PCT/AU2002/000865 patent/WO2003002102A1/en not_active Ceased
- 2002-07-01 EP EP02742515A patent/EP1411904A4/en not_active Ceased
-
2003
- 2003-12-23 CO CO03112102A patent/CO5540373A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1411904A4 (en) | 2006-06-07 |
| WO2003002102A1 (en) | 2003-01-09 |
| NZ529859A (en) | 2005-11-25 |
| CO5540373A2 (es) | 2005-07-29 |
| CN1731988A (zh) | 2006-02-08 |
| JP4800570B2 (ja) | 2011-10-26 |
| JP2004530721A (ja) | 2004-10-07 |
| CA2452030A1 (en) | 2003-01-09 |
| EP1411904A1 (en) | 2004-04-28 |
| AUPR602501A0 (en) | 2001-07-26 |
| AU2002344685B2 (en) | 2008-05-15 |
| US20040241204A1 (en) | 2004-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9405798A (pt) | Métodos para liberação in vivo de material biológico e composições úteis dos mesmos | |
| PT1183014E (pt) | Composicoes farmaceuticas orais de libertacao controlada e de dissimulacao de sabor | |
| BRPI0007487B8 (pt) | difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase | |
| BR0115531A (pt) | Tratamento de mucosites | |
| BR0212052A (pt) | Preparação de composição farmacêutica de liberação prolongada | |
| BR0107942A (pt) | Polìmeros de proteìna de liberação lenta | |
| TW200505402A (en) | Ophthalmic drug delivery device | |
| DE69332222D1 (de) | Enythropoietin enthaltendes arzneimittelabgabesystem | |
| BRPI0513300A (pt) | forma farmacêutica oral, protegida frente ao abuso, contendo (1r, 2r)-3-(3-dimetilamino-1-etil-2-propil)-fenol | |
| ES2037082T3 (es) | Una composicion para la liberacion controlada de un farmaco. | |
| DK1037667T3 (da) | Farmaceutiske hydrogelformuleringer, lægemiddelindgivelsesanordninger samt fremgangsmåder | |
| CO5540373A2 (es) | Composicion farmaceutica de liberacion sostenida | |
| BRPI0407747A (pt) | agente terapêutico para lesão à medula espinhal compreendendo antagonista de interleucinas-6 | |
| BR0210630A (pt) | Sistema fornecedor de liberação prolongada | |
| ES2183172T3 (es) | Procedimiento para la preparacion de microparticulas. | |
| HRP20010684B1 (hr) | Izravno stlaciva matrica za kontrolirano otpustanje jednostruke dnevne doze klaritromicina | |
| ATE212829T1 (de) | Feste, wasserfreie, pharmazeutische zubereitungen für vaginale verwendung | |
| DE69716469D1 (de) | Pharmazeutische zusammensetzung enthaltend ein osteogenese foerderndes mittel und ein polyethylen-glycol | |
| BR0214159A (pt) | Sistema farmacêutico radiopaco de liberação prolongada | |
| CY1108482T1 (el) | Συστημα υποδοριας διανομης, μεθοδος παρασκευης του και χρηση του για την αγωγη διαταραχων xολινεργικης ανεπαρκειας | |
| DE60108354D1 (de) | 2H-1-Benzopyran-Derivative, Prozesse zu ihrer Herstellung und Pharmazeutische Zusammensetzungen | |
| BR0015781A (pt) | Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea | |
| AR018376A1 (es) | Composiciones farmaceuticas que se pueden dispersar de una manera espontanea y el uso de las mismas para la manufactura de un medicamento | |
| WO2000063348A3 (fr) | Composition pharmaceutique comprenant des cellules nkt activees par des pim, et son utilisation en therapie | |
| ATE265234T1 (de) | Pharmazeutische zusammensetzung von hydrophob modifizierten hedgehog-proteinen und deren verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: VIRBAC CORPORATION (US) Free format text: TRANSFERIDO DE: SMART DRUG SYSTEMS INC. |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 13A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2313 DE 05-05-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 9/00 (2006.01), A61K 31/365 (2006.01), A61K 3 |